ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      68,114.16
      0.57%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Alexion Pharmaceuticals Inc (ALXN)

      7. Alexion Pharmaceuticals Inc (ALXN) News

      ALXN

      Alexion Pharmaceuticals (ALXN)

      Alexion Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ALXN
      DateTimeSourceHeadlineSymbolCompany
      02/04/20119:57AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      02/04/20119:51AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      02/03/201112:41PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/31/20116:30AMBusiness WireAlexion Acquires Taligen Therapeutics and Creates Translational Medicine Group to Accelerate Development of Expanded PortfolioNASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/28/20114:45PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/28/20114:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/28/20114:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/28/20114:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/27/201110:00AMBusiness WireAlexion Pharmaceuticals to Report Fourth Quarter and Full Year 2010 Results on Thursday, February 10, 2011NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/18/20114:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/18/20114:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/12/20111:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/12/20111:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/12/20111:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/12/20111:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/12/20111:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      01/04/201110:00AMBusiness WireAlexion to Present at the 29th Annual JP Morgan Healthcare ConferenceNASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/29/20105:55PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/29/20105:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/28/20104:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/15/20104:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/06/20104:13PMBusiness WireLong-Term Efficacy, Safety & Survival Outcomes of PNH Patients Treated with Soliris® (eculizumab) Reported at ASH Annual Mee...NASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/06/20109:30AMBusiness WireHemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNHNASDAQ:ALXNAlexion Pharmaceuticals Inc
      12/05/20109:30AMBusiness WireAlexion Reports Results from First Clinical Trial of Novel Anti-Cancer Antibody Samalizumab at ASH Annual MeetingNASDAQ:ALXNAlexion Pharmaceuticals Inc
      11/24/20104:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      11/24/201010:00AMBusiness WireAlexion to Present at the Piper Jaffray 22nd Annual Health Care ConferenceNASDAQ:ALXNAlexion Pharmaceuticals Inc
      11/23/20104:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      11/23/20104:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
      11/20/20108:30PMBusiness WirePhase 2 Study of Eculizumab (Soliris®) in Patients with aHUS Resistant to Plasma Therapy Met Primary & Secondary Endpoints w...NASDAQ:ALXNAlexion Pharmaceuticals Inc
      11/12/201010:17AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALXNAlexion Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ALXN

      Your Recent History

      ASX
      KZR
      Kalamazoo Resources
      NYSE
      SOV
      Sovereign Bancorp
      Delayed Upgrade Clock